Torisel Kit

Опис товару

About Torisel Kit

Torisel Kit is a medication containing the active ingredient Temsirolimus. Temsirolimus, sold under the brand name Torisel, is an intravenous drug for the treatment of renal cell carcinoma (RCC), developed by Wyeth Pharmaceuticals and approved by the U. S. Food and Drug Administration (FDA) in May 2007, and was also approved by the European Medicines Agency (EMA) in November 2007.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE Temsirolimus injection is indicated for the treatment of advanced renal cell carcinoma
• Used for: Temsirolimus injection is a kinase inhibitor indicated for the treatment of advanced renal cell carcinoma
• Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Temsirolimus, the active ingredient in Torisel Kit, is the pharmacologically active substance of this product. 1 INDICATIONS AND USAGE Temsirolimus injection is indicated for the treatment of advanced renal cell carcinoma. Temsirolimus injection is a kinase inhibitor indicated for the treatment of advanced renal cell carcinoma. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Torisel Kit. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Torisel Kit for extended periods without medical advice.